Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease

Based on the role of oxidative stress in the pathogenesis of Graves’ hyperthyroidism (GH) and Graves’ Orbitopathy (GO), a therapy with the antioxidant agent selenium has been proposed and a number of studies have been performed, both in vitro and in vivo. In GH, reactive oxygen species (ROS) contrib...

Full description

Bibliographic Details
Main Authors: Giulia Lanzolla, Michele Marinò, Claudio Marcocci
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Endocrinology
Subjects:
Graves’ hyperthyroidism
Graves’ orbitopathy
oxidative stress
reactive oxygen species
selenium
selenocysteine
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.608428/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2020.608428/full

Similar Items